Avantor Reports Return to Organic Revenue Growth in Third Quarter 2026
Avantor (AVTR) reported a return to organic revenue growth during its third quarter 2026 earnings call, highlighted by a 5.2% increase in organic revenue. The company saw significant momentum in its VWR laboratory distribution segment, which grew organic sales by 5.8% due to increased customer volume and expanded commercial sales initiatives. Operational improvements through the 'Revival' transformation program helped restore growth in the biomanufacturing products segment by increasing plant throughput. Additionally, strong free cash flow generation of $169 million allowed management to reduce net debt by $173 million, bringing the adjusted net leverage ratio to 3.1 times as they work toward a target below 3x.
Tickers: $AVTR
Topics: biopharma research spending debt reduction laboratory distribution organic revenue growth